12900 Results (Page 263 of 516)
All Market Research Reports
Turkey Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Turkey Lung Cancer Therapeutics Market will reach a value of $462 Mn from $238 Mn in 2022, growing at a CAGR of 8.6% during 2022-30. The Lung Cancer Therapeutics Market in Turkey is dominated by a few domestic pharmaceutical companies such as Silanes, Liomont, and PISA. The Lung Cancer Therapeutics Market in Turkey is segmented into different types of cancer and different therapy types. Some of the major factors affecting the Turkey lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies, and the presence of highly efficient drugs.
Turkey ENT Devices Market Analysis
Turkey's ENT Devices Market is projected to grow from $190 Mn in 2022 to $300 Mn by 2030, registering a CAGR of 6.3% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Turkey ENT devices market include Fako Elektronik, Vefa Medical, and Faromed.
Turkey ECG Equipments Market Analysis
Turkey's ECG Equipment Market is expected to witness growth from $71 Mn in 2022 to $130 Mn in 2030 with a CAGR of 7.80% for the forecasted year 2022-30. The demand for healthcare services and ECG equipment is rising in Turkey as a result of the country's older population. The market is segmented by product type and by end user. Some key players in this market include Ersamed Medikal, Acibadem Labmed, Megasan Medikal, Johnson & Johnson, Philipps Healthcare, Medtronic, GE Healthcare, and Nihon Kohden.
Turkey Dialysis Market Analysis
This report presents a strategic analysis of the Turkey Dialysis Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Turkey Dialysis Market, offering unmatched value, accuracy, and expert insights.
Turkey Diabetes Therapeutics Market Analysis
Turkey's diabetes therapeutics market is expected to witness growth from $1.1 Bn in 2022 to $2.5 Bn in 2030 with a CAGR of 10.2% for the forecasted year 2022-30. The rising awareness about diabetes and the supportive government policies to promote diabetes in Turkey are the major market drivers. The Turkey diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Nobel İlaç, Koçak Farma, and GlaxoSmithKline are the major players in the Turkey diabetes therapeutics market.
Turkey Diabetes Drugs Market Analysis
This report presents a strategic analysis of the Turkey Diabetes Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Turkey Diabetes Drugs Market, offering unmatched value, accuracy, and expert insights.
Turkey Coronary Stents Market Analysis
Turkey's Coronary Stents Market is expected to witness growth from $90 Mn in 2022 to $136 Mn in 2030 with a CAGR of 5.25% for the forecasted year 2022-30. The demand for coronary stents is anticipated to rise in Turkey as patients and healthcare professionals become more aware of the advantages of coronary stents. Manufacturers who invest in educational programs to spread the word about the advantages of coronary stents may be able to enhance their market share. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Ersamed Medikal, Acibadem Labmed, Megasan Medikal, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.
Turkey Contraceptive Devices Market Analysis
Turkey's Contraceptive Devices Market is expected to witness growth from $103 Mn in 2022 to $198 Mn in 2030 with a CAGR of 8.50% for the forecasted year 2022-30. The proportion of women working in Turkey has been rising significantly in recent years. As women balance their jobs with family planning and childrearing, this has led to a larger need for family planning and contraception. The market is segmented by type and by gender. Some key players in this market include Tubitak Marmara, Acibadem Labmed, Megasan Medikal, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
Turkey Clinical Diagnostics Market Analysis
This report presents a strategic analysis of the Turkey Clinical Diagnostics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Turkey Clinical Diagnostics Market, offering unmatched value, accuracy, and expert insights.
Turkey Cardiac Surgery Instruments Market Analysis
Turkey's Cardiac Surgery Instruments Market is expected to witness growth from $17 Mn in 2022 to $29 Mn in 2030 with a CAGR of 7.10% for the forecasted year 2022-30. Turkish healthcare is of a high caliber, and it is less expensive than that of other nations, making it a common destination for medical tourists. This has increased demand for medical equipment, including instruments used in cardiac surgery, and is predicted to propel market expansion. The market is segmented by type, application, and end user. Some key players in this market include Ersamed Medikal, Acibadem Labmed, Megasan Medikal, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Turkey Advanced Therapy Medicinal Products (ATMPs) Market Analysis
This report presents a strategic analysis of Turkey's Advanced Therapy Medicinal Products (ATMPs) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about Turkey's Advanced Therapy Medicinal Products (ATMPs) Market, offering unmatched value, accuracy, and expert insights.
Thailand ePharmacy Market Analysis
This report presents a strategic analysis of the Thailand ePharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Thailand ePharmacy Market, offering unmatched value, accuracy, and expert insights.
Thailand Robotic Surgery Services Market Analysis
This report presents a strategic analysis of the Thailand Robotic Surgery Services Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Thailand Robotic Surgery Services Market, offering unmatched value, accuracy, and expert insights.
Thailand Retail Pharmacy Market Analysis
This report presents a strategic analysis of the Thailand Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Thailand Retail Pharmacy Market, offering unmatched value, accuracy, and expert insights.
Thailand Radiotherapy Market Analysis
By 2030, it is anticipated that the Thailand Radiotherapy Market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-30. The Radiotherapy Therapeutics Market in Thailand is dominated by a few domestic players such as Bangkok Medical Supply, OTO-Medical, and Thai Radiology Equipment. The radiotherapy market in Thailand is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Thailand Radiotherapy is increasing due to the rise in cancer cases in the country.
Vietnam Addiction Therapeutics Market Analysis
Vietnam addiction therapeutics market was valued at $51 Mn in 2022 and is estimated to reach $88 Mn in 2030, exhibiting a CAGR of 7.13% during the forecast period. The growth of programs aimed at increasing drug knowledge and avoiding substance usage is one of the main drivers of the addiction therapeutics market. Dominant key players operating in the market include Indivior, Alkermes, Reckitt Benckiser, Otsuka Pharmaceutical Co., Pfizer, Mallinckrodt, Purdue Pharma L.P., GlaxoSmithKline, Teva Pharmaceutical and Novartis
UK Addiction Therapeutics Market Analysis
UK addiction therapeutics market was valued at $263 Mn in 2022 and is estimated to reach $385 Mn in 2030, exhibiting a CAGR of 4.9% during the forecast period. The addiction treatment industry is expanding due to a greater understanding and acceptance of substance use disorders as significant public health concerns. Major market players are Indivior, Reckitt Benckiser Pharmaceuticals, Camurus AB, Molteni Farmaceutici, Ethypharm, Martindale Pharma, Accord Healthcare, Sun Pharmaceutical Industries, Wockhardt UK and Martindale Pharma
UAE Addiction Therapeutics Market Analysis
UAE addiction therapeutics market was valued at $51 Mn in 2022 and is estimated to reach $93 Mn in 2030, exhibiting a CAGR of 7.9% during the forecast period. The rise in mental health awareness and awareness about addiction treatments through government encouragement and support has increased investments in addiction therapeutics infrastructure which has in turn reduced the social stigma associated with it. These changes in environment have led to an increase in the addiction treatment drug market in the UAE. Some major key players in UAE addiction therapeutics are Viatris, Sahara Pharmaceutical, AbbVie, Pfizer, Indivior, Reckitt Benckiser Pharmaceuticals, Mundipharma, Teva Pharmaceutical, Alkermes and Hikma
Thailand Patient Support Programs (PSP) Market Analysis
This report presents a strategic analysis of the Thailand Patient Support Programs (PSP) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Thailand Patient Support Programs (PSP) Market, offering unmatched value, accuracy, and expert insights.
Spain Addiction Therapeutics Market Analysis
Spain addiction therapeutics market was valued at $195 Mn in 2022 and is estimated to reach $308 Mn in 2030, exhibiting a CAGR of 5.9% during the forecast period. The market for addiction treatment is growing as a result of the growing understanding and recognition of substance use disorders as serious public health issues. Major market players are Indivior, Reckitt Benckiser Pharmaceuticals, Teva Pharmaceutical Industries, Mundipharma, Camurus AB, Grunenthal, Ethypharm, Molteni Farmaceutici, Lacer and Asofarma
South Africa Addiction Therapeutics Market Analysis
South Africa addiction therapeutics market was valued at $66 Mn in 2022 and is estimated to reach $123 Mn in 2030, exhibiting a CAGR of 8.13% during the forecast period. Public awareness has improved as a result of the anti-drug campaigns and encouraging government measures, and this has significantly expanded the addiction therapeutics market. Some of the leading companies in the market are Aspen Pharmacare, Adcock Ingram, Mylan Pharmaceuticals, Teva Pharmaceuticals, AbbVie, Reckitt Benckiser, Sun Pharma Industries, Cipla, Alkermes and Lupin Pharmaceuticals
Thailand Palliative Care Market Analysis
Thailand's Palliative care market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The main factors driving the growth would be as rising prevalence of chronic diseases, the improving healthcare industry, government support, and the aging population. The market is segmented by service type and by the end user. Some of the major players include Koon Hospital, Bangkok Hospital Chiang Mai, Chulalongkorn Hospital, Songklanagarind Hospital, and Siriraj Palliative Care Center.
Singapore Addiction Therapeutics Market Analysis
Singapore addiction therapeutics market was valued at $12 Mn in 2022 and is estimated to reach $22 Mn in 2030, exhibiting a CAGR of 7.5% during the forecast period. One of the main factors driving the addiction therapeutics market is the increase in drug awareness and prevention activities. Leading key players functioning in the market include Indivior, Alkermes, Reckitt Benckiser Pharmaceuticals, Otsuka Pharmaceutical, Pfizer, Mallinckrodt, Purdue Pharma L.P., GlaxoSmithKline, Teva Pharmaceutical, and Novartis AG.
Thailand Oncology Drugs Market Analysis
By 2030, it is anticipated that the Thailand oncology drugs market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-30. The oncology drugs market in Thailand is dominated by a few domestic pharmaceutical companies such as Siam Bioscience, GPO, and Mega Lifesciences. The oncology market in Thailand is segmented into different therapeutic areas and different treatment types. The major factors affecting the Thailand oncology drugs market are the increasing disease burden of non-communicable diseases like cancer and the lack of healthcare facilities for cancer treatment in most areas of Thailand.
Saudi Arabia Addiction Therapeutics Market Analysis
Saudi Arabia addiction therapeutics market was valued at $172 Mn in 2022 and is estimated to reach $327 Mn in 2030, exhibiting a CAGR of 8.4% during the forecast period. The market is growing as the government is committed to addressing substance abuse problems by increasing mental health awareness and accessibility and improving access to addiction treatment facilities. The key players in addiction therapeutics market are Eradah (Al Amal) Mental Health Complex, Taif Mental Health Hospital, KAAUH developmental Hospital, Pfizer, Novartis, GSK, Johns Hopkins Aramco Healthcare Dhahran, Dr. Sulaiman Al-Habib Medical Group, AbbVie and Saudi German Hospitals Group